Email updates

Keep up to date with the latest news and content from BMC Medical Genetics and BioMed Central.

Open Access Research article

Familial hypercholesterolemia mutations in Petrozavodsk: no similarity to St. Petersburg mutation spectrum

Tatiana Yu Komarova1, Victoria A Korneva2, Tatiana Yu Kuznetsova2, Alexandra S Golovina13, Vadim B Vasilyev1 and Michail Yu Mandelshtam13*

Author Affiliations

1 Department of Molecular Genetics, Institute for Experimental Medicine, NW Branch of Russian Academy of Medical Sciences, Pavlov Street, 12, St.Petersburg 197376, Russia

2 Department of Faculty Therapy, Infectious diseases and Epidemiology, Petrozavodsk State University, Lenin Street, 33, Petrozavodsk, Republic of Karelia 185910, Russia

3 Department of Biochemistry, St.Petersburg State University, Universitetskaya nab., 7/9, St.Petersburg 199034, Russia

For all author emails, please log on.

BMC Medical Genetics 2013, 14:128  doi:10.1186/1471-2350-14-128

Published: 27 December 2013

Abstract

Background

Familial hypercholesterolemia (FH) is a human monogenic disease induced by a variety of mutations with striking genetic diversity. Despite this variability recurrent mutations occur in each population studied, which allows both elucidating prevalent mutations and developing DNA diagnostic tools for the disease. Recent research of FH in St. Petersburg, Moscow and Novosibirsk (major cities in Russia) demonstrates that each megapolis has its own FH mutation spectrum sharing only small part of mutations with other populations in Russia and Europe. In order to optimize molecular-genetic diagnostic protocols for FH in Russia we studied mutation spectrum in other regions including Petrozavodsk, a smaller town in relatively close proximity to St. Petersburg.

Methods

The principal method was automated detection of single-strand conformation polymorphism followed by direct PCR amplified DNA sequencing.

Results

Twelve different mutations of the low density lipoprotein (LDL) receptor gene were detected in the Petrozavodsk sample (80 patients). Out of these twelve mutations, seven have never been described before (c.192_201delinsGGACTTCA, c. 195_196insT, c. 618 T > G, c. 1340C > G, c. 1686_1693delinsT, c. 1936C > A, c. 2191delG). Other five mutations (c. 58G > A, c. 925_931del, c. 1194C > T, c. 1532 T > C, c. 1920C > T) were previously characterized elsewhere. All new mutations are considered to be a probable cause of the FH in their carriers. Direct evidence of the neutral character of c.58G > A or p. (Gly20Arg) is provided for the first time. Each pathogenic mutation was a trait of its own unique pedigree and so far has not been found in other patients.

Conclusions

Strikingly, out of twelve mutations characterized in the Petrozavodsk sample only one mutation, c. 925_931del, has previously been found in patients from St. Petersburg and Finland (most closely located studied populations), suggesting some common roots in origin of these populations in the past or limited gene exchange between them nowadays. No recurrent mutations were detected.